Interactive program
Tuesday 19 March 2024
-
Standard presentation 400 Hall
Afternoon (CET)
UPDATE ON SEPSIS BIOMARKERS
Moderator(s):
Djillali Annane (Garches, France)
Lieuwe Bos (Amsterdam, Netherlands)
Lieuwe Bos (Amsterdam, Netherlands)
-
-
Are they ready for routine use?
Jan De Waele (Ghent, Belgium)
-
-
How biomarkers can guide the duration of antimicrobial therapy
Jan De Waele (Ghent, Belgium)
Wednesday 20 March 2024
-
Standard presentation Copper Hall
Morning (CET)
SEPSIS MANAGEMENT
Moderator(s):
Philippe Montravers (Paris, France)
Mervyn Singer (London, United Kingdom)
Mervyn Singer (London, United Kingdom)
-
-
Source control at 4 am rather than 8 am
Jan De Waele (Ghent, Belgium)
-
Standard presentation Copper Hall
Afternoon (CET)
OPTIMIZING ANTIBIOTIC THERAPY
Moderator(s):
Julie Helms (Strasbourg, France)
Christian Stoppe (Würzburg and Berlin, Germany)
Christian Stoppe (Würzburg and Berlin, Germany)
-
-
Continuous infusion of betalactam antibiotics – finally there?
Jan De Waele (Ghent, Belgium)
-
-
SDD does improve outcomes
Jan De Waele (Ghent, Belgium)
Thursday 21 March 2024
-
Round table The Arc Room
Morning (CET)
-
-
Optimal antibiotic dosages
Jan De Waele (Ghent, Belgium)
Patrick Honoré (Yvoir, Belgium)
Nicole Hunfeld (Rotterdam, Netherlands)
Despoina Koulenti (London, United Kingdom)
-
Meet the experts Demo box 2
Afternoon (CET)
-
-
Severe skin and soft tissue infections
Jan De Waele (Ghent, Belgium)
Philippe Montravers (Paris, France)
Friday 22 March 2024
-
Tutorial The Arc Room
Morning (CET)
-
-
Acute pancreatitis
Jan De Waele (Ghent, Belgium)